Search - tctmd.com

Displaying 41 - 60 of 235

Sort: Relevancy | Date

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Daily News

Signal of Aortic Stenosis Risk With Celecoxib

Michael O'Riordan

March 05, 2019

News Conference News STS 2019

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

Yael L. Maxwell

February 06, 2019

News Daily News

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

L.A. McKeown

February 06, 2019

News Daily News

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

L.A. McKeown

January 10, 2019

News Daily News

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

Todd Neale

January 09, 2019

News Daily News

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Yael L. Maxwell

December 10, 2018

News Daily News

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Todd Neale

November 20, 2018

News Opinion Conversations in Cardiology

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

November 16, 2018

News Conference News PCR London Valves 2018

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Shelley Wood

September 11, 2018

News Daily News

TAVR Learning Curve, Volume-Outcome Relationship Highlighted in International Registry

Todd Neale

September 11, 2018

Story 2: STS Data: Mitral Valve Cases Are Fastest-Growing Surgical Intervention in North America

News Daily News

STS Data: Mitral Valve Cases Are Fastest-Growing CV Surgical Intervention in North America

L.A. McKeown

July 25, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

News Conference News The Structural Heart Disease Summit 2018

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

Michael O'Riordan

June 23, 2018

News Conference News The Structural Heart Disease Summit 2018

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Michael O'Riordan

June 22, 2018

News Conference News The Structural Heart Disease Summit 2018

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Michael O'Riordan

June 21, 2018

News Conference News EuroPCR 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Caitlin E. Cox

May 25, 2018

News Daily News

Delayed Coronary Obstruction After TAVR: Prevalence, Causes, and Solution Explored for Deadly Complication

Yael L. Maxwell

April 02, 2018

News Conference News ACC 2018

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Caitlin E. Cox

March 19, 2018

News Conference News ISET 2018

Next-Generation Large-Bore Closure Devices Arrive

Caitlin E. Cox

February 05, 2018

Advertisement

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Signal of Aortic Stenosis Risk With Celecoxib

Redo Surgery for Bioprosthetic Aortic Valve Failure on the Decline Since 2015

NOTION and UK TAVI Report Good Long-term Function of Transcatheter Aortic Valves

Cancer Patients Should Not Be Automatically Ruled Out for TAVR: Analysis

Continuing Anticoagulation During TAVR in A-fib Patients May Be Safe, Study Suggests

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

FORWARD Registry: Low Mortality Rate Seen 1 Year After TAVR With Evolut R

Conversations in Cardiology: Can a Patient With Tissue Valves Switch From Warfarin to a NOAC?

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

TAVR Learning Curve, Volume-Outcome Relationship Highlighted in International Registry

STS Data: Mitral Valve Cases Are Fastest-Growing CV Surgical Intervention in North America

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications

High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense?

Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Delayed Coronary Obstruction After TAVR: Prevalence, Causes, and Solution Explored for Deadly Complication

Urgent/Emergent TAVR: Risky but Rewarding, TVT Registry Data Hint

Next-Generation Large-Bore Closure Devices Arrive

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content